Incidence, causes, and outcomes of dilated cardiomyopathy in children.
By J. Towbin, A. Lowe, S. Colan, L. Sleeper, E. Orav, S. Clunie, Jane E. Messere, Gerald F. Cox, P. Lurie, D. Hsu and 3 more. Journal of the American Medical Association (JAMA), 2006
997 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/9d509583c48f618a7e5fd9f5bfcc5d12c4e897ea
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “57 cases per 100 000.(350) Potentially pathogenic genetic mutations are found in at least 20% of adults with DCM and between 10 and 20% of relatives have evidence for disease on clinical screening.”
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2013, background): “Similarly, biopsy-proven myocarditis is reported in 9–16% of adult patients with unexplained non-ischaemic dilated cardiomyopathy (DCM)(6,7) and in 46%ofchildrenwith an identifiedcauseofDCM.(8) In patientspresenting with mild symptoms and minimal ventricular dysfunction, myocarditis often resolves s”